Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CALCR | P30988 | 4/20 | 0.65 |
| ▸ | GLP1R | P43220 | 7/20 | 0.64 |
| ▸ | CCKBR | P32239 | 4/20 | 0.64 |
| ▸ | NMBR | P28336 | 2/20 | 0.64 |
| ▸ | GRPR | P30550 | 2/20 | 0.64 |
| ▸ | GCGR | P47871 | 3/20 | 0.62 |
| ▸ | CALCA | P06881 | 2/20 | 0.62 |
| ▸ | NPY1R | P25929 | 1/20 | 0.62 |
| ▸ | NPY2R | P49146 | 1/20 | 0.62 |
| ▸ | NPY4R | P50391 | 1/20 | 0.62 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.62 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.61 |
| ▸ | CXCR4 | P61073 | 1/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29588160 | 0.98 | CALCR (0.66) | CALCRGLP1RCCKBRNMBRGRPR | |
| SCHEMBL29588702 | 0.97 | CALCR (0.64) | CALCRGLP1RCCKBRNMBRGRPR | |
| SCHEMBL29588523 | 0.97 | CALCR (0.68) | CALCRGLP1RCCKBRNMBRGRPR | |
| SCHEMBL29587876 | 0.96 | CALCR (0.65) | CALCRGLP1RCCKBRNMBRGRPR | |
| SCHEMBL30540291 | 0.95 | CALCR (0.61) | CALCRGLP1RCCKBRNMBRGRPR | |
| SCHEMBL29020839 | 0.94 | NMBR (0.67) | CALCRGLP1RCCKBRNMBRGRPR | |
| SCHEMBL20534072 | 0.94 | NMBR (0.67) | CALCRGLP1RCCKBRNMBRGRPR | |
| Acetic Acid SCHEMBL29378226 | 0.94 | NMBR (0.66) | CALCRGLP1RCCKBRNMBRGRPR | |
| SCHEMBL25311922 | 0.94 | NMBR (0.65) | CALCRGLP1RCCKBRNMBRGRPR | |
| SCHEMBL31000889 | 0.91 | GLP1R (0.71) | CALCRGLP1RCCKBRNMBRGRPR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250345389-A1 | COMBINATION THERAPIES | GILEAD SCIENCES INC (US) | 2025-11-13 | — | — | US | disclosed |
| CN-114478709-A | Long-acting hepatitis virus entry inhibitor | 成都奥达生物科技有限公司 | 2022-05-13 | — | — | CN | disclosed |